67808-66-6

Usage

Uses

Used in Chemical Research:
Methyl 2-formyl-4-thiophenecarboxylate is used as a research compound for its unique combination of a thiophene ring, an ester group, and an aldehyde group. Its potential applications in organic synthesis make it a valuable tool for scientists exploring new chemical reactions and pathways.
Used in Pharmaceutical Industry:
Methyl 2-formyl-4-thiophenecarboxylate is used as an intermediate in the synthesis of pharmaceutical compounds. Its functional groups can be utilized to create new drug molecules with potential therapeutic applications.
Used in Specialty Chemical Industry:
Methyl 2-formyl-4-thiophenecarboxylate is used as a building block in the production of specialty chemicals. Its unique structure and functional groups can be incorporated into various chemical products, such as dyes, pigments, and other industrial chemicals.
Note: Due to the limited information available on the toxicity and safety of Methyl 2-formyl-4-thiophenecarboxylate, its uses are primarily in specialized chemical research or industry, and not for general consumer applications.

InChI:InChI=1/C7H6O3S/c1-5(9)10-6-2-7(3-8)11-4-6/h2-4H,1H3

Upstream product

• 89324-44-7 3-carboxy-thiophene-5-carboxaldehyde 
• 74-88-4 methyl iodide 
• 58267-85-9 2-(4-bromo-thiophen-2-yl)-[1,3]dioxolane 

Downstream Products

• 191934-27-7 methyl 5-(bromomethyl)thiophene-3-carboxylate 
• 882004-79-7 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-9-ylmethyl]thiophen-3-carboxylic acid methyl ester hydrochloride salt 

Relevant academic research and scientific papers

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, (R4)n and ring (A) are as described in the description, to their preparation, to pharmaceutically acc

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.

TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE

The present invention relates to compounds of the formula (I), wherein R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to thei

Disubstituted aryl and heteroaryl imines having retinoid-like biological activity

Compounds of the formula STR1 wherein the R 1 groups independently are hydrogen, lower alkyl, or two geminal R 1 groups jointly represent an oxo ( O) or a thio ( S) group; R 2 is hydrogen or lower alkyl, or halogen; M is or --N CR 4 -- or --R 4 C N-- where R 4 is hydrogen or lower alkyl; X is C(R 1) 2 ; Y is phenyl optionally substituted with an R 3 group which is lower alkyl or halogen; A is (CH 2) n where n is 0-5, lower branched chain alkyl, cycloalkyl, alkenyl, alkynyl; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8, CONR 9 R 10, --CH 2 OH, CH 2OR 11, CH 2 OCOR 11, CHO, CH(OR 12) 2, CHOR 13 O, --COR 7, CR 7 (OR 12) 2, or CR 7 OR 13 O, where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons have retinoid-like biological activity.

3-SUBSTITUTED-2-OXINDOLE DERIVATIVES

This invention relates to novel 3-substituted-2-oxindole derivatives which are inhibitors of prostaglandin H 2 synthase, 5-lipoxygenase and interleukin-1 biosynthesis. The compounds of the invention are useful as inhibitors of prostaglandin H 2 synthase and interleukin-1 biosynthesis, per se, and as analgesic, antiinflammatory and antiarthritic agents in the treatment of chronic inflammatory diseases. This invention also relates to pharmaceutical compositions comprising said 3-substituted-2-oxindole derivatives; to methods of inhibiting prostaglandin H 2 synthase and biosynthesis of interleukin-1; and to treating chronic inflammatory diseases in a mammal with said compounds. Further, this invention relates to certain novel carboxylic acids useful as intermediates in the preparation of the 3-substituted-2-oxindole derivatives of this invention and to a process for the preparation of the 3-substituted-2-oxindole derivatives.